ARK™ Meperidine Assay 5039-0001-01

GUDID 00812101030134

The ARK™ Meperidine Assay is intended for the qualitative and/or semiquantitative determination of meperidine in human urine at cutoff concentrations of 100 ng/mL. The assay is intended for use in laboratories with automated clinical chemistry analyzers. This in vitro diagnostic device is for prescription use only.

ARK DIAGNOSTICS INC

Pethidine IVD, kit, enzyme immunoassay (EIA)
Primary Device ID00812101030134
NIH Device Record Keyacf4f504-3670-4a22-a170-7b2e04a29946
Commercial Distribution StatusIn Commercial Distribution
Brand NameARK™ Meperidine Assay
Version Model Number5039-0001-01
Catalog Number5039-0001-01
Company DUNS164880598
Company NameARK DIAGNOSTICS INC
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kittrue
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Customer Support Contacts

Phone5102706270
Emailcustomersupport@ark-tdm.com

Operating and Storage Conditions

Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing AgencyDevice ID
GS100812101030134 [Primary]

FDA Product Code

DJGEnzyme Immunoassay, Opiates

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2019-07-30
Device Publish Date2019-07-22

On-Brand Devices [ ARK™ Meperidine Assay]

00812101030134The ARK™ Meperidine Assay is intended for the qualitative and/or semiquantitative determinati
00812101030127The ARK™ Meperidine Assay is intended for the qualitative and/or semiquantitative determinati

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.